<div id="readability-page-1" class="page"><div><ul> <li>Recently, Blue Bird moved to acquire Girardin’s 50% stake in the Micro Bird joint venture, aiming for full control of operations and an expanded range of Buy America–compliant school buses, while its Chief Operating Officer Jeffrey Scott Sanfrey sold 5,192 company shares.</li> <li>This combination of consolidating a key JV and refining leadership share exposure highlights Blue Bird’s continued efforts to align its product mix and governance with evolving policy and manufacturing priorities.</li> <li>We’ll now examine how full ownership of the Micro Bird JV could influence Blue Bird’s investment narrative and long-term business profile.</li> </ul><p>The future of work is here. Discover the 29 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.</p><h2>Blue Bird Investment Narrative Recap</h2><p>To own Blue Bird, you really have to believe in long term demand for cleaner, modern school buses supported by policy incentives and fleet replacement. The Micro Bird buyout slightly reinforces the near term catalyst of expanding Buy America compliant offerings, while tariff and policy volatility around EV funding still looks like the key risk that could unsettle backlogs and order timing in the short run.</p> <p>Among recent announcements, the reaffirmed FY2026 revenue outlook of about US$1.5 billion is especially relevant here, because full control of Micro Bird sits alongside that guidance. Together, they frame how Blue Bird is positioning its product mix and manufacturing footprint to support those revenue ambitions if funding programs and school district budgets hold up.</p> <p>Yet despite this progress, investors should be aware that heavy reliance on government funding could become a bigger concern if...</p> <p>Read the full narrative on Blue Bird (it's free!)</p><p>Blue Bird's narrative projects $1.6 billion revenue and $152.3 million earnings by 2028. This requires 4.0% yearly revenue growth and roughly a $36 million earnings increase from $115.9 million today.</p><p>Uncover how Blue Bird's forecasts yield a $63.75 fair value, a 16% upside to its current price.</p><h2>Exploring Other Perspectives</h2><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/892df4ca-74da-4814-add4-a705659cefdd/chart/quote-price?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/892df4ca-74da-4814-add4-a705659cefdd/chart/quote-price"/><figcaption>BLBD 1-Year Stock Price Chart</figcaption></figure> <p>While the consensus story focuses on steady growth and policy support, the most optimistic analysts were already modeling about US$1.6 billion in revenue and roughly US$159.0 million in earnings by 2028, so you should expect that this new Micro Bird deal and the COO share sale could shift both that bullish view and the risks around funding dependence in different directions.</p><p>Explore 4 other fair value estimates on Blue Bird - why the stock might be worth just $63.75!</p><h2>The Verdict Is Yours</h2><p>Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.</p><ul><li>A great starting point for your Blue Bird research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision.</li><li>Our free Blue Bird research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Blue Bird's overall financial health at a glance.</li></ul><h2>Ready For A Different Approach?</h2><p>Our top stock finds are flying under the radar-for now. Get in early:</p><ul><li>We've uncovered the 16 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.</li><li>The latest GPUs need a type of rare earth metal called Dysprosium and there are only 29 companies in the world exploring or producing it. Find the list for free.</li><li>AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data     and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your     financial situation. We aim to bring you long-term focused analysis driven by fundamental data.     Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.     Simply Wall St has no position in any stocks mentioned.</em></p><div><h3>Valuation is complex, but we're here to simplify it.</h3><p>Discover if Blue Bird might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><p>Access Free Analysis</p></div></div></div>

BLBD

MOTO

<p>Blue Bird has acquired Girardin’s 50% stake in the Micro Bird joint venture, aiming for full control and an expanded range of Buy America-compliant school buses. COO Jeffrey Scott Sanfrey sold 5,192 shares, indicating a strategic shift in leadership share exposure. This move aligns with Blue Bird's goal to enhance its product mix and governance amid evolving policies. The company projects $1.6 billion in revenue and $152.3 million in earnings by 2028, but reliance on government funding poses risks. Analysts suggest the Micro Bird deal may influence growth expectations and funding concerns.</p>

Does Blue Bird’s Micro Bird Buyout and Insider Sale Reframe Its Strategic Story for BLBD?